Truist cuts James Hardie stock price target on homebuilding outlook
Truist Securities reduced its price target for James Hardie (JHX) to $37 from $40, citing weaker North American homebuilding outlook. The company's Q2 FY2027 results beat expectations, but guidance was in line. JHX stock has a 65% return over the past year and a P/E ratio of 109. Other analysts have mixed views, with some revising earnings downwards and others raising price targets. The company also announced the sale of its European business for $980 million.
How this was made
The 30-second read
Why it matters
The combination of a price‑target cut and strategic divestiture creates mixed signals for the stock.
Market read
Analyst downgrade may drive short‑term weakness, while strategic moves could support longer‑term outlook.
What to watch
Recent revenue and EBITDA guidance upgrades and the sale of the European business could offset the downside.
Background
James Hardie reported Q2 FY2027 results above expectations and announced the sale of its European walling business to Holcim.
Ticker impact
Truist Securities lowered its price target on James Hardie Industries to $37 from $40, citing weaker North American new construction outlook.
likely downward pressure as the market prices in the reduced target
The price‑target cut is a fresh analyst action that can trigger short‑term selling.
Market effects
The downgrade reflects concerns about the North American construction sector, which may affect other building‑materials companies.
Potential negative sentiment for U.S. construction‑related stocks.
Limited to the building‑materials sector; no broad market impact.
Counterpoint
Some investors may view the lower target as an entry point if they believe the construction outlook will improve.
Key entities
- companyJames Hardie Industries
Building‑materials manufacturer listed on NYSE (JHX).
- analystTruist Securities
Equity research firm that lowered the price target.


